Previous Article | Next Article ![]()
Molecular and Cellular Biology, August 2001, p. 5396-5407, Vol. 21, No. 16
Department of Biochemistry and Molecular
Biology, Monash University, Victoria 3800,1
and Nuclear Signaling Laboratory, John Curtin School of
Medical Research, Australian National University, Canberra ACT
2601,2 Australia
Received 17 May 2001/Accepted 18 May 2001
Proteinase inhibitor 9 (PI-9) is a human serpin present in the
cytoplasm of cytotoxic lymphocytes and epithelial cells. It inhibits
the cytotoxic lymphocyte granule proteinase granzyme B (graB) and is
thought to protect cytotoxic lymphocytes and bystander cells from
graB-mediated apoptosis. Following uptake into cells, graB promotes DNA
degradation, rapidly translocating to the nucleus, where it binds a
nuclear component. PI-9 should therefore be found in cytotoxic
lymphocyte and bystander cell nuclei to ensure complete protection
against graB. Here we demonstrate by microscopy and subcellular
fractionation experiments that PI-9 is present in the nuclei of human
cytotoxic cells, endothelial cells, and epithelial cells. We also show
that the related serpins, PI-6, monocyte neutrophil elastase inhibitor
(MNEI), PI-8, plasminogen activator inhibitor 2 (PAI-2), and the
viral serpin CrmA exhibit similar nucleocytoplasmic distributions.
Because these serpins lack classical nuclear localization signals and
are small enough to diffuse through nuclear pores, we investigated
whether import occurs actively or passively. Large (~70 kDa) chimeric
proteins comprising PI-9, PI-6, PI-8, MNEI, or PAI-2 fused to green
fluorescent protein (GFP) show similar nucleocytoplasmic distributions
to the parent proteins, indicating that nuclear import is active. By
contrast, CrmA-GFP is excluded from nuclei, indicating that CrmA is not
actively imported. In vitro nuclear transport assays show that PI-9
accumulates at a rate above that of passive diffusion, that it requires
cytosolic factors but not ATP, and that it does not bind an
intranuclear component. Furthermore, PI-9 is exported from nuclei via a
leptomycin B-sensitive pathway, implying involvement of the export
factor Crm1p. We conclude that the nucleocytoplasmic distribution of PI-9 and related serpins involves a nonconventional nuclear import pathway and Crm1p.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.16.5396-5407.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Nucleocytoplasmic Distribution of the Ovalbumin Serpin PI-9
Requires a Nonconventional Nuclear Import Pathway and the Export
Factor Crm1
*
Corresponding author. Mailing address: Department of
Biochemistry and Molecular Biology, P.O. Box 13D, Monash University, Victoria 3800, Australia. Phone: 61 3 9905 3771. Fax: 61 3 9905 4699. E-mail: Phil.Bird{at}med.monash.edu.au.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|